Applied DNA Sciences Inc
APDN5.620USD
0.000
Close 12/24, 13:00（ET）Quotes delayed by 15 min
5.07MMarket Cap
LossP/E TTM
More Details of Applied DNA Sciences Inc Company
Applied DNA Sciences, Inc. is a biotechnology company. The Company is engaged in developing and commercializing technologies to produce and detect deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). The Company operates through three segments: Therapeutic DNA Production Services, MDx Testing Services, and DNA Tagging and Security Products and Services. Therapeutic DNA Production Services segment operations consist of the enzymatic manufacture of synthetic DNA for use in the production of nucleic acid-based therapeutics and, the development and sale of a proprietary RNAP for use in the production of messenger RNA (mRNA) therapeutics. MDx Testing Service segment operations consist of performing and developing clinical molecular diagnostic and genetic tests and clinical laboratory testing services. DNA Tagging and Security Products and Services segment operations consist of the manufacture and detection of DNA for industrial supply chains and security services.
Applied DNA Sciences Inc Info
Ticker SymbolAPDN
Company nameBNB Plus Corp
IPO dateAug 24, 2001
CEOShorrock (Clay)
Number of employees46
Security typeOrdinary Share
Fiscal year-endAug 24
Address50 Health Sciences Drive
CitySTONY BROOK
Stock exchangeNASDAQ Capital Market Consolidated
CountryUnited States of America
Postal code11790
Phone16312408800
Websitehttps://adnas.com/
Ticker SymbolAPDN
IPO dateAug 24, 2001
CEOShorrock (Clay)
Company Executives of Applied DNA Sciences Inc
Name
Name/Position
Position
Shareholding
Change
Mr. Joshua (Josh) Kruger
Mr. Joshua (Josh) Kruger
Chairman of the Board
Chairman of the Board
75.30K
--
Mr. Clay Shorrock, J.D.
Mr. Clay Shorrock, J.D.
Chief Executive Officer
Chief Executive Officer
18.70K
+467275.00%
Ms. Beth M. Jantzen
Ms. Beth M. Jantzen
Chief Financial Officer
Chief Financial Officer
18.69K
+623033.33%
Mr. Robert B. (Bob) Catell
Mr. Robert B. (Bob) Catell
Independent Director
Independent Director
1.00
--
Mr. Joseph D. Ceccoli
Mr. Joseph D. Ceccoli
Independent Director
Independent Director
1.00
--
Ms. Judith Murrah
Ms. Judith Murrah
Director
Director
1.00
-66.67%
Dr. Yacov A. Shamash, Ph.D.
Dr. Yacov A. Shamash, Ph.D.
Independent Director
Independent Director
1.00
--
Ms. Elizabeth M. Schmalz Shaheen
Ms. Elizabeth M. Schmalz Shaheen
Independent Director
Independent Director
--
--
Mr. Sanjay M. Hurry
Mr. Sanjay M. Hurry
Executive Director - Investor Relations and Corporate Communications
Executive Director - Investor Relations and Corporate Communications
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Joshua (Josh) Kruger
Mr. Joshua (Josh) Kruger
Chairman of the Board
Chairman of the Board
75.30K
--
Mr. Clay Shorrock, J.D.
Mr. Clay Shorrock, J.D.
Chief Executive Officer
Chief Executive Officer
18.70K
+467275.00%
Ms. Beth M. Jantzen
Ms. Beth M. Jantzen
Chief Financial Officer
Chief Financial Officer
18.69K
+623033.33%
Mr. Robert B. (Bob) Catell
Mr. Robert B. (Bob) Catell
Independent Director
Independent Director
1.00
--
Mr. Joseph D. Ceccoli
Mr. Joseph D. Ceccoli
Independent Director
Independent Director
1.00
--
Ms. Judith Murrah
Ms. Judith Murrah
Director
Director
1.00
-66.67%
Revenue Breakdown
Currency: USDUpdated: Mon, Oct 6
Currency: USDUpdated: Mon, Oct 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2021
FY2020
FY2019
By BusinessUSD
Name
Revenue
Proportion
Product and authentication services - Large scale DNA production
161.00K
52.89%
Product and authentication services - Supply chain
91.32K
30.00%
Research and development services
52.07K
17.11%
Relevant data have not been disclosed by the company yet.
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Product and authentication services - Large scale DNA production
161.00K
52.89%
Product and authentication services - Supply chain
91.32K
30.00%
Research and development services
52.07K
17.11%
Shareholding Stats
Updated: Wed, Dec 24
Updated: Wed, Dec 24
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Kruger (Joshua)
1.72%
FNY Investment Advisers LLC
0.69%
Schmalz (Elizabeth M.)
0.52%
Ceccoli (Joseph D)
0.52%
Shamash (Yacov A)
0.52%
Other
96.04%
Shareholders
Shareholders
Proportion
Kruger (Joshua)
1.72%
FNY Investment Advisers LLC
0.69%
Schmalz (Elizabeth M.)
0.52%
Ceccoli (Joseph D)
0.52%
Shamash (Yacov A)
0.52%
Other
96.04%
Shareholder Types
Shareholders
Proportion
Individual Investor
2.59%
Investment Advisor/Hedge Fund
0.80%
Bank and Trust
0.10%
Investment Advisor
0.07%
Hedge Fund
0.02%
Other
96.42%
Institutional Shareholding
Updated: Mon, Dec 8
Updated: Mon, Dec 8
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q4
62
12.01K
1.97%
+3.60K
2025Q3
64
19.08K
7.51%
-74.50K
2025Q2
62
93.59K
3.11%
+68.02K
2025Q1
58
35.01K
5.59%
+11.41K
2024Q4
55
23.97K
30.73%
+2.04K
2024Q3
51
1.16K
3.54%
+725.00
2024Q2
53
1.30K
7.24%
+394.00
2024Q1
46
185.00
329.31%
-6.00
2023Q4
44
114.00
24.92%
-67.00
2023Q3
47
182.00
32.27%
+23.00
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Jantzen (Beth M)
3.00
0%
--
--
Apr 03, 2025
Shorrock (Clay)
4.00
0%
--
--
Apr 03, 2025
UBS Switzerland AG
493.00
0.04%
+493.00
--
Jun 30, 2025
View more
Related ETFs
Name
Proportion
No Data
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
May 29, 2025
Merger
15→1
Mar 12, 2025
Merger
50→1
Mar 12, 2025
Merger
50→1
Mar 12, 2025
Merger
50→1
Mar 12, 2025
Merger
50→1
Apr 22, 2024
Merger
20→1
Date
Type
Ratio
May 29, 2025
Merger
15→1
Mar 12, 2025
Merger
50→1
Mar 12, 2025
Merger
50→1
Mar 12, 2025
Merger
50→1
Mar 12, 2025
Merger
50→1
Apr 22, 2024
Merger
20→1
Apr 22, 2024
Merger
20→1
Apr 22, 2024
Merger
20→1
Apr 22, 2024
Merger
20→1
FAQs
Who are the top five shareholders of Applied DNA Sciences Inc?
The top five shareholders of Applied DNA Sciences Inc are:
Jantzen (Beth M) holds 3.00 shares, accounting for 0.00% of the total shares.
Shorrock (Clay) holds 4.00 shares, accounting for 0.00% of the total shares.
UBS Switzerland AG holds 493.00 shares, accounting for 0.04% of the total shares.
Jantzen (Beth M) holds 3.00 shares, accounting for 0.00% of the total shares.
Shorrock (Clay) holds 4.00 shares, accounting for 0.00% of the total shares.
UBS Switzerland AG holds 493.00 shares, accounting for 0.04% of the total shares.
What are the top three shareholder types of Applied DNA Sciences Inc?
The top three shareholder types of Applied DNA Sciences Inc are:
Kruger (Joshua)
FNY Investment Advisers LLC
Schmalz (Elizabeth M.)
Kruger (Joshua)
FNY Investment Advisers LLC
Schmalz (Elizabeth M.)
How many institutions hold shares of Applied DNA Sciences Inc (APDN)?
As of 2025Q4, 62 institutions hold shares of Applied DNA Sciences Inc, with a combined market value of approximately 12.01K, accounting for 1.97% of the total shares. Compared to 2025Q3, institutional shareholding has increased by -5.54%.
What is the biggest source of revenue for Applied DNA Sciences Inc?
In FY2025Q3, the Product and authentication services - Large scale DNA production business generated the highest revenue for Applied DNA Sciences Inc, amounting to 161.00K and accounting for 52.89% of total revenue.
